Publications 2012

Leptin as an immunomodulator.

Procaccini C, Jirillo E, Matarese G.
Mol Aspects Med. 2012 Feb;33(1):35-45. doi: 10.1016/j.mam.2011.10.012.

Intracellular metabolic pathways control immune tolerance.

Procaccini C, Galgani M, De Rosa V, Matarese G.
Trends Immunol. 2012 Jan;33(1):1-7. doi: 10.1016/j.it.2011.09.002.

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.

Malfitano AM, Laezza C, Galgani M, Matarese G, D'Alessandro A, Gazzerro P, Bifulco M.
Pharmacol Res. 2012 Mar;65(3):365-71. doi: 10.1016/j.phrs.2011.11.008.

Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus.

Liu Y, Yu Y, Matarese G, La Cava A.
J Immunol. 2012 Mar 1;188(5):2070-3. doi: 10.4049/jimmunol.1102835.

Ob-stopping obesity, metabolic and immune-mediated disorders.

Matarese G, De Rosa V.
Structure. 2012 Mar 7;20(3):385-7. doi: 10.1016/j.str.2012.02.005.

In vivo veritas, in vitro artificia.

Matarese G, La Cava A, Horvath TL.
Trends Mol Med. 2012 Aug;18(8):439-42. doi: 10.1016/j.molmed.2012.05.003.

Immunological functions of leptin and adiponectin.

Carbone F, La Rocca C, Matarese G.
Biochimie. 2012 Oct;94(10):2082-8. doi: 10.1016/j.biochi.2012.05.018.

At the crossroad of T cells, adipose tissue, and diabetes.

Matarese G, Procaccini C, De Rosa V.
Immunol Rev. 2012 Sep;249(1):116-34. doi: 10.1111/j.1600-065X.2012.01154.x.

Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses.

Procaccini C, De Rosa V, Galgani M, Carbone F, Cassano S, Greco D, Qian K, Auvinen P, Cal G, Stallone G, Formisano L, La Cava A, Matarese G.
J Immunol. 2012 Sep 15;189(6):2941-53. doi: 10.4049/jimmunol.1200935.

Regulatory T cells, mTOR kinase, and metabolic activity.

Procaccini C, Matarese G.
Cell Mol Life Sci. 2012 Dec;69(23):3975-87. doi: 10.1007/s00018-012-1058-6.